BCG Vaccine Market, Size, Share, Opportunities and Forecast, 2020-2027

SKU: DHC404 | Last Updated On: Feb 24 2021 | No. of Pages: 180 | Available Formats

> Global BCG Vaccine Market Expected to reach a high CAGR By 2027: DataM Intelligence

Global BCG Vaccine Market Is Segmented By Product Segment By (Immune BCG, Therapy BCG), By Demographics Segment (Pediatrics (0-18 Years), Adults (19-35 Years), By Application Segment (Hospitals, Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2020-2027

 

Market Overview

The Global BCG Vaccine Market is expected to grow at a CAGR during the forecasting period (2020-2027).

The only vaccine available to combat Tuberculosis is the Bacillus Calmette-Gurin (BCG) vaccine (TB). One dose is recommended for healthy babies near the time of birth in countries with a high incidence of Tuberculosis. However, only infants at high risk are usually immunized in areas where Tuberculosis is rare, while confirmed cases of Tuberculosis are personally screened and administered. It is also possible to immunize individuals who are not afflicted with Tuberculosis and who have not been recently immunized yet are also susceptible to drug-resistant Tuberculosis.

Product: DataM Intelligence Analysis (2019)

Market Dynamics

The major factors propelling the growth of the BCG vaccine market are Increases in tuberculosis prevalence, especially in developing and underdeveloped countries, as well as technical developments in the field of vaccine research. Also, the rising birth rates across the globe, especially in China and India, contribute to the market's significant growth. Also, the rise in government policies and a global emphasis on immunization programs further drive demand growth. It is expected that untapped business opportunities in emerging regions can have multiple market growth prospects.

Increasing prevelance of Tuberculosis in developing and under-developed countries

The increasing prevalence of Tuberculosis across the globe, especially in developing and under-developed countries such as India, China, Africa, will stir the demand for BCG vaccine as it is the only vaccine available for the disease. As per the TB Alert organization, It is estimated that a fifth of the global population is afflicted with latent TB. Of these individuals, one in ten will begin to contract the disorder. And about 10 million individuals develop TB annually, contributing to 1.6 million deaths. Also, as per the Global Tuberculosis Report of 2018, the majority of TB patients (66%) live in one of eight countries: India (27%), China (9%), Indonesia (8%), the Philippines (6%), Pakistan (5%), Nigeria (4%), Bangladesh (4%) or South Africa (3 percent ). This high prevalence in emerging countries drives the market for BCG vaccines during the forecast period.

Side effects of BCG vaccine

The side effects of BCG vaccine among individuals are a key factor expected to curtail the global market's growth over the forecast period. Moreover, the shortage of supply in BCG vaccine in emerging countries is another factor expected to hinder the total market's growth in the near future. As UNICEF administered a shortage of 16.7 million BCG vaccines due to less supply capacity.

COVID-19 Impact Analysis

The outbreak of COVID-19 has negatively impacted the growth of the BCG vaccine market globally. The disruption in the supply chain has majorly impacted the growth of the market amidst the pandemic. The escalated focus on COVID-19 vaccine development has led to de-escalation in BCG vaccines. Therefore, the COVID-19 pandemic has hampered the market value of the BCG Vaccine market in 2020.

BCG Vaccine Market Segment Analysis

Based on the product, the BCG vaccine market has been classified into Immune BCG and Therapy BCG

Immune BCG segment is projected to be the dominated segment in the market during the forecast period.

Immune BCG dominated the global market in 2019. Also, the Immune BCG is expected to present considerable growth in the near future. BCG Vaccine is administered to new borns in the risk zone areas with a single dose of Immune BCG to prevent TB development. Therefore, the increasing usage of Immune BCG in the prevention of the development of TB is expected to propel segmental growth in the near future.

BCG Vaccine is segmented on the basis of Demographics, which includes Pediatrics (0-18 Years), Adults (19-35 Years).

Pediatrics (0-18 Years) is expected to dominate the BCG Vaccine market.

Pediatrics (0-18 Years) held the dominant position in the global market during the forecast period. In countries where the BCG vaccine is part of the national childhood immunization policy, BCG is normally offered to all children up to one year of age. In addition, older children (over 1 year of age) who have an elevated chance of contracting Tuberculosis should also be given this vaccine. It is rarely administered above 16 years of age and is never administered above 35 years of age, since vaccines are only successful when administered at an early stage of life.  This is supporting the segment growth during the forecast period.

Product: DataM Intelligence Analysis (2019)

BCG Vaccine is segmented on the basis of Application, which includes Hospitals, Clinics, Others

Hospitals is expected to dominate the BCG Vaccine market.

Hospitals held the dominant position in the global market during the forecast period. The administration of BCG vaccines done after the birth of baby in the hospitals supports the segment growth during the forecast period. Moreover, the Clinics is expected to project a considerable CAGR during the forecast period. Older children (more than 1 year of age) who have an elevated risk of contracting Tuberculosis may also receive this vaccine administered at Clinics.

BCG Vaccine Market Geographical Analysis

Based on geography, the study analyzes the BCG vaccine market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

Asia Pacific is expected to dominate the global BCG Vaccine market

Asia Pacific held a dominant position in the global BCG vaccine market in 2019. In Asia, the India is expected to represent considerable growth during the forecast period. In India, the prevalence of TB was 27% of the total in 2018. Moreover, Middle East and Africa are expected to represent significant growth in value during the forecast period. BCG Vaccine market for Asia Pacific is expected to observe rapid growth over the forecast period, backed by the growth of the tuberculosis cases in the region coupled with increasing government initiatives to combat the disease.

Competitive Landscape

The BCG vaccine market is highly competitive, owing to the presence of major developments in vaccine production. The key BCG Vaccine players which are contributing to the growth of the global market include Merck & Co., Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotech Group (a subsidiary of China National Pharmaceutical Group Corporation), Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited (GSBPL), and Statens Serum Institute among others. The major players are adopting new product launch and expansion strategies for global growth in the BCG Vaccine market.  

TICE® BCG (Merk & Co. Inc.):

TICE® BCG is an attenuated live culture preparation for intravesical use of the Mycobacterium bovis strain Bacillus of Calmette and Guerin (BCG).1 The TICE strain was developed from a strain originating at the Pasteur Institute at the University of Illinois.  At the local site of administration, TICE® BCG causes a granulomatous reaction. Intra-vesical. TICE BCG has been used as a treatment for recurring tumors and prophylaxis against them in Patients of urinary bladder carcinoma in situ (CIS) and to avoid recurrence of Stage III TaT1 papillary bladder tumors are at high risk for recurrence.

Product Portfolio: The Company’s portfolio comprises Vaccines, Medications and medical devices among others

Why Purchase the Report?

  • Visualize the BCG Vaccine market segmentation composition by product, demographics, application and Region, highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the BCG Vaccine market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of BCG vaccine market - level 3 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global BCG Vaccine market report would provide access to an approx. 51 market data table, 45 figures and 221 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Suggestions for Related Market Report:

  • Global Tuberculosis Market
  • Global Vaccine market

 

 

Table of Contents

  1. BCG Vaccine Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. BCG Vaccine Market – Market Definition and Overview

  3. BCG Vaccine Market – Executive Summary

    1. Market Snippet by Product
    2. Market Snippet by Demographics
    3. Market Snippet by Application
    4. Market Snippet by Region
  4. BCG Vaccine Market – Market Dynamics

    1. Market Impacting Factors
      1. Drivers
        1. Increasing Prevalence of Tuberculosis in Developing and under-developed countries
        2. Increasing birth rates across the globe
      2. Restraints:
        1. Side effects of BCG vaccine
      3. Impact Analysis
  5. BCG Vaccine Market – Industry Analysis

    1. Porter's Five Forces Analysis
    2. Supply Chain Analysis
    3. Value Chain Analysis
    4. PEST Analysis
    5. Pricing Analysis
    6. Regulatory Analysis
    7. Reimbursement Analysis
    8. Unmet Needs
    9. Patent Trends
  6. BCG Vaccine Market – COVID-19 Analysis

    1. Analysis of Covid-19 on the Market
      1. Before COVID-19 Market Scenario
      2. Present COVID-19 Market Scenario
      3. After COVID-19 or Future Scenario
    2. Pricing Dynamics Amid Covid-19
    3. Demand-Supply Spectrum
    4. Government Initiatives Related to the Market During Pandemic
    5. Manufacturers Strategic Initiatives
    6. Conclusion 
  7. BCG Vaccine Market – By Product

    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
    3. Market Attractiveness Index, By Product Segment
      1. Immune BCG*
        1. Introduction
        2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
      2. Therapy BCG
  8. BCG Vaccine Market – By Demographics

    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics Segment
    3. Market Attractiveness Index, By Demographics Segment
      1. Pediatrics (0-18 Years)*
        1. Introduction
        2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
      2. Adults (19-35 Years)
  9. BCG Vaccine Market – By Application

    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    3. Market Attractiveness Index, By Application Segment
      1. Hospitals*
        1. Introduction
        2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
      2. Clinics
  10. BCG Vaccine Market – By Region

    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    3. Market Attractiveness Index, By Region
    4. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. U.S.
        2. Canada
        3. Mexico
    5. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    6. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    7. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    8. Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  11. BCG Vaccine Market – Competitive Landscape

    1. Competitive Scenario
    2. Market Positioning/Share Analysis
    3. Mergers and Acquisitions Analysis
  12. BCG Vaccine Market- Company Profiles

    1. Merck & Co.*
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Sanofi Pasteur
    3. Japan BCG Laboratory
    4. China National Biotech Group
    5. Serum Institute of India Pvt. Ltd
    6. InterVax Ltd
    7. GREENSIGNAL BIO PHARMA LIMITED (GSBPL)
    8. STATENS SERUM INSTITUTE
    9. Other companies (List Not Exhaustive)
  13. BCG Vaccine Market – Premium Insights

  14. BCG Vaccine Market – DataM Intelligence Analysis

    1. Appendix
    2. About Us and Services
    3. Contact Us

 

List of Tables Figures

List of Tables

Table 1 Global BCG Vaccine Market Value, By Product, 2019, 2023 & 2027 (US$ Million)

Table 2 Global BCG Vaccine Market Value, By Demographics, 2019, 2023 & 2027 (US$ Million)

Table 3 Global BCG Vaccine Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 4 Global BCG Vaccine Market Value, By Region, 2019, 2023 & 2027 (US$ Million)

Table 5 North America BCG Vaccine Market Value, By Product, 2019, 2023 & 2027 (US$ Million)

Table 6 North America BCG Vaccine Market Value, By Demographics, 2019, 2023 & 2027 (US$ Million)

Table 7 Global BCG Vaccine Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 8 North America BCG Vaccine Market Value, By Country, 2018-2027 (US$ Million)

Table 9 South America BCG Vaccine Market Value, By Product, 2019, 2023 & 2027 (US$ Million)

Table 10 South America BCG Vaccine Market Value, By Demographics, 2019, 2023 & 2027 (US$ Million)

Table 11 Global BCG Vaccine Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 12 South America BCG Vaccine Market Value, By Country, 2018-2027 (US$ Million)

Table 13 Europe BCG Vaccine Market Value, By Product, 2019, 2023 & 2027 (US$ Million)

Table 14 Europe BCG Vaccine Market Value, By Demographics, 2019, 2023 & 2027 (US$ Million)

Table 15 Global BCG Vaccine Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 16 Europe BCG Vaccine Market Value, By Country, 2018-2027 (US$ Million)

Table 17 Asia Pacific BCG Vaccine Market Value, By Product, 2019, 2023 & 2027 (US$ Million)

Table 18 Asia Pacific BCG Vaccine Market Value, By Demographics, 2019, 2023 & 2027 (US$ Million)

Table 19 Global BCG Vaccine Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 20 Asia Pacific BCG Vaccine Market Value, By Country, 2019, 2023 & 2027 (US$ Million)

Table 21 The Middle East & Africa BCG Vaccine Market Value, By Product, 2019, 2023 & 2027 (US$ Million)

Table 22 The Middle East & Africa BCG Vaccine Market Value, By Demographics, 2019, 2023 & 2027 (US$ Million)

Table 23 Global BCG Vaccine Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 24 The Middle East & Africa BCG Vaccine Market Value, By Country, 2019, 2023 & 2027 (US$ Million)

Table 25 Merck & Co.: Overview

Table 26 Merck & Co.: Product Portfolio

Table 27 Merck & Co.: Key Developments

Table 28  Sanofi Pasteur: Overview

Table 29  Sanofi Pasteur: Product Portfolio

Table 30  Sanofi Pasteur: Key Developments

Table 31  Japan BCG Laboratory: Overview

Table 32  Japan BCG Laboratory: Product Portfolio

Table 33  Japan BCG Laboratory: Key Developments

Table 34 China National Biotech Group: Overview

Table 35 China National Biotech Group: Product Portfolio

Table 36 China National Biotech Group: Key Developments

Table 37 Serum Institute of India Pvt. Ltd: Overview

Table 38 Serum Institute of India Pvt. Ltd: Product Portfolio

Table 39 Serum Institute of India Pvt. Ltd: Key Developments

Table 40 InterVax Ltd: Overview

Table 41 InterVax Ltd: Product Portfolio

Table 42 InterVax Ltd: Key Developments

Table 43 GREENSIGNAL BIO PHARMA LIMITED (GSBPL): Overview

Table 44 GREENSIGNAL BIO PHARMA LIMITED (GSBPL): Product Portfolio

Table 45 GREENSIGNAL BIO PHARMA LIMITED (GSBPL): Key Developments

Table 46 STATENS SERUM INSTITUTE: Overview

Table 47 STATENS SERUM INSTITUTE: Product Portfolio

Table 48 STATENS SERUM INSTITUTE: Key Developments

 

List of Figures

Figure 1 Global BCG Vaccine Market Share, By Product, 2019 & 2027 (%)

Figure 2 Global BCG Vaccine Market Share, By Demographics, 2019 & 2027 (%)

Figure 3 Global BCG Vaccine Market Share, By Application, 2019 & 2027 (%)

Figure 4 Global BCG Vaccine Market Share, By Region, 2019 & 2027 (%)

Figure 5 Global BCG Vaccine Market Value, 2018-2027 (US$ Million)

Figure 6 Global BCG Vaccine Market Y-o-Y Growth, By Product, 2019-2027 (%)

Figure 7 Immune BCG: Global BCG Vaccine Market Value, 2018-2027 (US$ Million)

Figure 8 Therapy BCG: Global BCG Vaccine Market Value, 2018-2027 (US$ Million)

Figure 9 Global BCG Vaccine Market Y-o-Y Growth, By Demographics, 2019-2027 (%)

Figure 10 Pediatrics (0-18 Years): Global BCG Vaccine Market Value, 2018-2027 (US$ Million)

Figure 11 Adults (19-35 Years)s: Global BCG Vaccine Market Value, 2018-2027 (US$ Million)

Figure 12 Global BCG Vaccine Market Share, By Application, 2019 & 2027 (%)

Figure 13 Hospitals: Global BCG Vaccine Market Value, 2018-2027 (US$ Million)

Figure 14 Clinics: Global BCG Vaccine Market Value, 2018-2027 (US$ Million)

Figure 15 Global BCG Vaccine Market Y-o-Y Growth, By Region, 2019-2027 (%)

Figure 16 North America BCG Vaccine Market Value, 2018-2027 (US$ Million)

Figure 17 North America BCG Vaccine Market Share, By Product, 2019 & 2027 (%)

Figure 18 North America BCG Vaccine Market Share, By Demographics, 2019 & 2027 (%)

Figure 19 North America BCG Vaccine Market Share, By Application, 2019 & 2027 (%)

Figure 20 North America BCG Vaccine Market Share, By Product, 2019 & 2027 (%)

Figure 21 North America BCG Vaccine Market Share, By Country, 2019 & 2027 (%)

Figure 22 South America BCG Vaccine Market Value, 2018-2027 (US$ Million)

Figure 23 South America BCG Vaccine Market Share, By Product, 2019 & 2027 (%)

Figure 24 South America BCG Vaccine Market Share, By Demographics, 2019 & 2027 (%)

Figure 25 South America BCG Vaccine Market Share, By Application, 2019 & 2027 (%)

Figure 26 South America BCG Vaccine Market Share, By Country, 2019 & 2027 (%)

Figure 27 Europe BCG Vaccine Market Value, 2018-2027 (US$ Million)

Figure 28 Europe BCG Vaccine Market Share, By Product, 2019 & 2027 (%)

Figure 29 Europe BCG Vaccine Market Share, By Demographics, 2019 & 2027 (%)

Figure 30 Europe BCG Vaccine Market Share, By Application, 2019 & 2027 (%)

Figure 31 Europe BCG Vaccine Market Share, By Country, 2019 & 2027 (%)

Figure 32 Asia-Pacific BCG Vaccine Market Value, 2018-2027 (US$ Million)

Figure 33 Asia-Pacific BCG Vaccine Market Share, By Product, 2019 & 2027 (%)

Figure 34 Asia-Pacific BCG Vaccine Market Share, By Demographics, 2019 & 2027 (%)

Figure 35 Asia-Pacific BCG Vaccine Market Share, By Application, 2019 & 2027 (%)

Figure 36 Asia-Pacific BCG Vaccine Market Share, By Country, 2019 & 2027 (%)

Figure 37 The Middle East & Africa BCG Vaccine Market Value, 2018-2027 (US$ Million)

Figure 38 The Middle East & Africa BCG Vaccine Market Share, By Product, 2019 & 2027 (%)

Figure 39 The Middle East & Africa BCG Vaccine Market Share, By Demographics, 2019 & 2027 (%)

Figure 40 The Middle East & Africa BCG Vaccine Market Share, By Application, 2019 & 2027 (%)

Figure 41 The Middle East & Africa BCG Vaccine Market Share, By Country, 2019 & 2027 (%)

Figure 42 Merck & Co.: Financials

Figure 43  Sanofi Pasteur: Financials

Figure 44  Japan BCG Laboratory: Financials

Figure 45 China National Biotech Group: Financials

Figure 46 Serum Institute of India Pvt. Ltd: Financials

Figure 47 InterVax Ltd: Financials

Figure 48 GREENSIGNAL BIO PHARMA LIMITED (GSBPL): Financials

Figure 49 STATENS SERUM INSTITUTE: Financials

 

 

 

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Get your FREE SAMPLE PROPOSAL with a single click!

linkedinpinterest